The present invention relates to novel substituted aralkyl derivatives of the general formula (I) and (IIIa), their derivatives, their analogs, their tautomeric forms, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates, pharmaceutical compositions containing them, use of these compounds in medicine and the intermediates involved in their preparation.
本发明涉及一种新的通式(I)和(IIIa)的取代芳基烷基衍
生物,它们的衍
生物,类似物,互变异构体,药学上可接受的盐,药学上可接受的溶剂化合物,包含它们的制药组合物,以及这些化合物在医学上的应用和其制备中所涉及的
中间体。